Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 3919-3927

  Emmanuilidis, K ^a   Weighardt, H ^a   Maier, S ^a   Gerauer, K ^a   Fleischmann, T ^a   Zheng, X X ^a   Hancock, W W ^a   Holzmann, B ^a   Heidecke, C D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL PERITONITIS; FEMALE; HOST RESISTANCE; INFECTION RISK; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 0035478590     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.3919     Document Type: Article

References (58)

1. Immunosuppressive and anti-inflammatory properties of interleukin 10
2. Properties and functions of interleukin-10
3. Interleukin-10: An anti-inflammatory cytokine with therapeutic potential
4. Interleukin 10 protects mice from lethal endotoxemia
5. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
6. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
7. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia
8. Neutralization of IL-10 increases lethality in endotoxemia: Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor
9. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation
10. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis
11. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): Evidence for IL-10-enhanced cell death in EAT
12. Immunoregulatory role of interleukin 10 in rheumatoid arthritis
13. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
14. Interleukin-10-deficient mice develop chronic enterocolitis
15. Paradoxial priming effects of IL-10 on cytokine production
16. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18
17. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhihits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ
18. The functional characterization of interleukin-10 receptor expression on human natural killer cells
19. IL-10, a novel growth cofactor for mature and immature T cells
20. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
21. Interleukin 10: A novel stimulatory factor for mast cells and their progenitors
22. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells
23. A single amino acid determines the immunostimulatory activity of interleukin 10
24. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebocontrolled trial
25. Treatment of Gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin
26. Double-blind randomized controlled trial of monoclonal antibody 10 human tumor necrosis factor in treatment of septic shock
27. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis
28. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
29. Dysregulation of in vitro cytokine production by monocytes during sepsis
30. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β
31. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
32. Sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production
33. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery
34. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production
35. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection
36. Essential role of γ-interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis
37. Transient suppression of maerophage functions by liposome-encapsulated drugs
38. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
39. Massive chemokine transcription in acute renal failure due to polymicrobial sepsis
40. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications
41. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection
42. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate
43. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
44. Endogenous IL-10 protects mice from death during septic peritonitis
45. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge
46. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens
47. What is the role of IL-10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?
48. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
49. Exogenous IL-10 fails to decrease the mortality or morbidity of sepsis
50. Mechanism of splenic immunosuppression during sepsis: Key role of Kupffer cell mediators
51. Gadolinium chloride treatment attenuates hepatic platelet accumulation after lipopolysaccharide administration
52. Differential effects of hemorrhage on Kupffer cells: Decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6, TNF) release
53. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells
54. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice
55. Proinflammatory effects of IL-10 during human endotoxemia
56. + Thl-like responses
57. Enhanced THl activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
58. Role of interleukin-10 in regulation of T cell-dependent and T cell-independent mechanisms of resistance to Toxoplasma gondii